{"id":"W4407339263","doi":"10.1016/j.jaci.2024.12.622","title":"ALPHA-ORBIT - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Navenibart in Adolescent and Adult Participants with Type 1 and Type 2 Hereditary Angioedema (HAE)","year":2025,"lang":"en","type":"article","venue":"Journal of Allergy and Clinical Immunology","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Double blind; Placebo; Multicenter study; Medicine; Randomized controlled trial; Orbit (dynamics); Pediatrics; Internal medicine; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001781994,0.001526653,0.002958696,0.0003454022,0.0005275312,0.001124148,0.0008278377,0.001588091,0.006309227],"category_scores_gemma":[0.001355846,0.0006246105,0.0014388,0.0003227887,0.00140098,0.001280514,0.0003458262,0.003207073,0.0008889841],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006457262,"about_ca_system_score_gemma":0.001343891,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001143213,"about_ca_topic_score_gemma":0.002911305,"domain_scores_codex":[0.9995868,0.0001987265,0.0000230908,0.00007691026,0.00003460968,0.00007988772],"domain_scores_gemma":[0.9992212,0.0002123132,0.0001968896,0.0000621644,0.00004935024,0.0002580912],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9822582,0.004641682,0.0005726519,0.0003487668,0.0007068246,0.00003754413,0.00005084237,0.0001740099,0.002401131,0.0001364243,0.000677306,0.007994594],"study_design_scores_gemma":[0.9692978,0.02902363,0.0008227439,0.00001557322,0.0001832875,0.00002537359,0.00001403285,0.0001611196,0.0001537375,0.00007450276,0.0002224458,0.00000593044],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9866041,0.004532048,0.001004323,0.0007654625,0.0005797595,0.003291964,0.0009584529,0.0002120375,0.002051842],"genre_scores_gemma":[0.9828745,0.003324455,0.002219027,0.001685088,0.0005617979,0.004381732,0.001298851,0.00005161022,0.003602929],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006309227,"threshold_uncertainty_score":0.02110654,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04992839005709944,"score_gpt":0.3863522468350143,"score_spread":0.3364238567779149,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}